What is the best management approach for a patient with communicating hydrocephalus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Communicating Hydrocephalus

The definitive management of communicating hydrocephalus requires cerebrospinal fluid (CSF) diversion—either temporary external drainage for acute symptomatic cases or permanent shunt placement for chronic symptomatic disease—with treatment urgency and modality determined by acuity of presentation. 1

Acute Symptomatic Communicating Hydrocephalus

Urgent CSF diversion through external ventricular drainage (EVD) or lumbar drainage must be performed immediately to improve neurological outcomes. 2

EVD Placement and Management

  • EVD is the preferred method in acute settings as it allows continuous intracranial pressure monitoring and controlled CSF drainage. 3
  • Implement a bundled EVD protocol that addresses insertion technique, aseptic management, dressing protocols, CSF sampling frequency, and staff education to reduce infection rates (which range from <1% to 45% without standardized protocols). 2, 3
  • Key protocol elements include: aseptic insertion technique, appropriate skin preparation, standardized catheter selection, defined CSF sampling protocols, systematic dressing changes, and comprehensive staff training. 2

Lumbar Drainage Alternative

  • Lumbar drainage can be used when ventricular access is challenging or contraindicated, though it provides less control over intracranial pressure monitoring. 2, 3

Critical Pitfall to Avoid

  • Do not perform prolonged EVD weaning protocols (>24 hours) as they are ineffective in reducing the need for permanent shunting and only delay definitive treatment. 1, 3

Chronic Symptomatic Communicating Hydrocephalus

Permanent CSF diversion through ventriculoperitoneal, ventriculoatrial, or lumboperitoneal shunt placement is recommended to improve neurological outcomes. 2, 1

Treatment Indications

The American College of Neurology recommends treating when patients demonstrate: 4

  • The classic triad: gait disturbance (cardinal symptom in ~70% of patients with "magnetic" or "glued to floor" pattern), cognitive impairment, and urinary incontinence
  • Ventriculomegaly on imaging not attributable to cerebral atrophy or congenital enlargement
  • Positive predictive testing showing clinical improvement after CSF removal (via lumbar puncture or external lumbar drainage for 3-5 days)
  • Supportive imaging features: temporal horn enlargement, callosal angle <90°, periventricular white matter changes, widened sylvian fissures with effaced sulci, or aqueductal flow void on MRI

Expected Outcomes

  • Patients have an 80-90% chance of responding to shunt surgery with potential improvement in all symptoms. 4
  • Serious complication rate is approximately 6%. 4
  • Chronic shunt-dependent hydrocephalus occurs in 8.9% to 48% of patients with subarachnoid hemorrhage. 2, 1

Diagnostic Workup

  • MRI head without IV contrast is the preferred initial imaging modality to assess ventricular size, transependymal edema, and supportive features. 4, 3
  • Contrast-enhanced MRI helps distinguish between communicating and non-communicating types. 1
  • Lumbar puncture with opening pressure measurement aids diagnosis in communicating hydrocephalus. 1
  • Elevated aqueductal CSF stroke volume on phase-contrast MRI demonstrates high positive predictive value for shunt responsiveness. 4

Pharmacological Management: What NOT to Do

Avoid pharmacological treatments as they are ineffective for communicating hydrocephalus:

  • Do not use acetazolamide or furosemide as they do not reduce shunt need or effectively treat hydrocephalus. 1, 3
  • Do not use serial lumbar punctures as routine treatment to avoid shunt placement, as they neither predict nor prevent the need for permanent CSF diversion. 1, 3
  • Do not use intraventricular thrombolytics (tPA, urokinase, streptokinase) as they increase secondary hemorrhage risk without reducing shunt need. 1, 3

Special Circumstances

Increased Intracranial Pressure

  • For patients with opening pressure ≥250 mm H₂O, initiate repeated lumbar punctures to reduce pressure to 50% of opening pressure or 200 mm H₂O (whichever is greater), repeated daily for at least 4 days. 4

Pediatric Posthemorrhagic Hydrocephalus

  • Temporary surgical options include ventricular access devices (VADs), EVDs, or ventriculosubgaleal (VSG) shunts. 1
  • VSG shunts reduce the need for daily CSF aspiration compared with VADs in premature infants. 1
  • Do not use serial lumbar punctures routinely to reduce shunt placement need in premature infants. 1

Underlying Etiology

  • When hydrocephalus is secondary to infection, hemorrhage, or tumor, address the underlying cause concurrently with CSF diversion. 1

Monitoring and Follow-up

Monitor for EVD complications including: 3

  • Infection (implement bundled protocols to minimize risk)
  • Hemorrhage
  • Catheter malfunction
  • Overdrainage

References

Guideline

Management of Communicating Hydrocephalus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Normal Pressure Hydrocephalus in the ICU

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Indications for Treating Communicating Hydrocephalus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.